NCT00243841View on ClinicalTrials.gov

Dose Escalation Study for Primary Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Carcinoma, Hepatocellular
Interventions
RADIATION

Stereotactic Body Radiation

Arm A: Childs A - receive 3 fractions. Arm B: Childs B - receive 5 fractions.

Trial Locations (1)

46202

Indiana University Department of Radiation Oncology, Indianapolis

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

Indiana University School of Medicine

OTHER

NCT00243841 - Dose Escalation Study for Primary Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter